GYRE Operating Cash Flow (Statement)
Gyre Therapeutics Inc · Operating Cash Flow (Statement)
GYRE Operating Cash Flow (Statement)
Latest reported-$14.50Mperiod ending
GYRE Cash from Operations (-$25.04M → -$14.50M)
Annual operating cash flow (statement)
High-resolution chart · PNG
GYRE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 1,010,000 | |
| -3,641,000 | |
| 25,892,000 | |
| 10,677,000 | |
| -83,755,000 | |
| -55,048,000 | |
| -43,613,000 | |
| -28,553,000 | |
| -19,940,000 | |
| -18,472,000 | |
| -19,118,000 | |
| -34,483,000 | |
| -40,612,000 | |
| -64,239,000 | |
| -83,718,000 | |
| 138,298,000 | |
| -24,271,000 | |
| -28,261,000 | |
| 24,838,076 | |
| -9,892,277 | |
| -26,246,516 | |
| -25,036,628 |